Gelium

NTLA: Consolidation.

Long
Gelium Updated   
NASDAQ:NTLA   Intellia Therapeutics, Inc.
A rollback to the area of 50% of the last uptrend was bought out. A broad consolidation has been formed, which can be broken upward with a minimum target of around 140.
Trade closed: target reached:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.